Lescol
Company: Novartis
Approval Status: Approved September 1997
Treatment for: coronary atherosclerosis
Areas: Cardiology/Vascular Diseases; Endocrinology
Possible similar drugs: Lescol; Lescol XL
General Information
Other Useful Resources
Lescol has been approved for a new indication--a treatment to decrease the progression of coronary atherosclerosis in patients with coronary heart disease undergoing treatment programs to lower lipoprotein cholesterol. Lescol was originally approved in 1994 for patients with primary hypercholesterolemia.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
Medical Dictionary Searches
